Angel News

Angel News

Back to Homepage

6th April 2018

Liverpool ChiroChem raises £1.5m

Liverpool ChiroChem (LCC), the specialist Liverpool-based chemical intermediates company, has raised £1.5m in equity finance to support the Company’s growth plans and increase production capacity overseas. The new fundraise round was led by Praetura Capital and the Northern Powerhouse Investment Fund (NPIF), and supported by long standing investor Deepbridge Capital.

The Company, originally a spin-out from Liverpool University, has the capability to produce exceptionally pure chemical forms using its own patented technology and has already established itself firmly within the pharmaceutical and drug discovery supply chain. Founded just three years ago, it counts over 70 pharma, biotech and agrochemicals customers including Merck, Novartis, Domainex, Syngenta and Bayer.


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage